Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
EGL Genetic Diagnostics, |
RCV000177784 | SCV000229715 | uncertain significance | not provided | 2014-10-28 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000795712 | SCV000935182 | uncertain significance | Nemaline myopathy 2 | 2019-02-20 | criteria provided, single submitter | clinical testing | This sequence change replaces valine with leucine at codon 1241 of the NEB protein (p.Val1241Leu). The valine residue is moderately conserved and there is a small physicochemical difference between valine and leucine. This variant is present in population databases (rs537769519, ExAC 0.001%). This variant has not been reported in the literature in individuals with NEB-related disease. ClinVar contains an entry for this variant (Variation ID: 196899). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |